Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2012
12/05/2012CN102805716A Preparation method of beautyberry herbal hand cleaner
12/05/2012CN102805275A Feed and traditional Chinese medicine compound used for treating colibacillosis of chicken and preparation method of feed and traditional Chinese medicine compound
12/05/2012CN102327569B Preparation method and application method of drug and herbal medicine thereof for curing chronic hepatitis B
12/05/2012CN102327227B Preparation method of polyethylene glycol-poly(gamma-amino-epsilon-caprolactone) nano particle loaded with glycyrrhetic acid
12/05/2012CN102302490B Medicine composition of imipenem-cilastatin-tazobactam
12/05/2012CN102258758B High-content liquid gingerols and preparation method thereof
12/05/2012CN102258552B Method for preparing angelica dahurica decoction pieces
12/05/2012CN102218092B Dispersion tablets of traditional Chinese medicine composition
12/05/2012CN102206595B Apostichopus japonicus antagonistic bacterium and its application
12/05/2012CN102198105B Nafcillin sodium injection and preparation method thereof
12/05/2012CN102188395B Stable meropenem injection and preparation method thereof
12/05/2012CN102151260B Andrographolide and berberine combination and application thereof
12/05/2012CN102140461B Small interfering nucleic acid and medical composite and pharmaceutical applications of nucleic acid
12/05/2012CN102030807B Theasapogenol derivative with anti-HIV (Human Immunodeficiency Virus) activity, preparation method and application thereof
12/05/2012CN102026644B Controlled activation of the reuterin-production machinery of lactobacillus reuteri
12/05/2012CN101974072B Escherichia coli TolC antigen as well as antibody and application thereof
12/05/2012CN101919840B Application of B/E ring substituted silybin for preparing medicament for treating virus hepatitis B
12/05/2012CN101885760B HIV-1gp120 gene consensus sequence optimized by codon and gp120 nucleic acid vaccine
12/05/2012CN101885757B Avian influenza hemagglutinin, epitope peptide, monoclonal antibodies for resisting avian influenza hemagglutinin and epitope peptide, and applications of monoclonal antibodies
12/05/2012CN101810186B Multifunctional disinfectant and preparation method thereof
12/05/2012CN101808639B Antifungal pharmaceutical composition
12/05/2012CN101756988B Compound matrine and diversine nano-emulsion preparation and preparation method thereof
12/05/2012CN101653437B Novel application of sulfonic benzo-gamma-pyrone compound
12/05/2012CN101602733B Diaryl pyridine derivatives, preparation method thereof and application thereof
12/05/2012CN101549083B Chinese materia medica foot bath preserving health essence
12/05/2012CN101516858B Crystalline antifungal compounds
12/05/2012CN101495636B DNA vaccine for koi herpes virus (KHV) disease
12/05/2012CN101455687B Active extract of facultative anaerobic red marine bacteria and production method and use thereof
12/05/2012CN101386641B Synthetic peptide vaccines for foot-and-mouth disease
12/05/2012CN101379055B Substituted quinolones III
12/05/2012CN101370517B Peptide derived from hepatitis C virus
12/05/2012CN101367869B Polypeptide for preventing, diagnosing and treating hepatitis E virus, and vaccine as diagnosis agent of the same
12/05/2012CN101277740B Antituberculous composition comprising oxazole compounds
12/05/2012CN101133158B 人抗狂犬病抗体及其用途 Human anti-rabies antibodies and their use
12/05/2012CN101045725B Malate and multicrystal object of some quinolone compound
12/04/2012US8324379 Prodrugs of heteroaryl compounds
12/04/2012US8324354 Streptococcal antigenic protein for use in generation of vaccines to prevent microorganismal infection
12/04/2012US8324283 Solid pharmaceutical compositions comprising a SIP receptor agonist and a sugar alcohol
12/04/2012US8324223 Substituted thieno [2,3-d] pyrimidines as HIV inhibitors
12/04/2012US8324198 Monocarbams
12/04/2012US8324148 Delivering to the subject a compound comprising a nuclear localization sequence of NF-kB such that nuclear importation of NF-kB is inhibited
12/04/2012US8323962 Molecules with extended half-lives, compositions and uses thereof
12/04/2012US8323679 Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same
12/04/2012US8323660 Method for identification, isolation and production of antigens to a specific pathogen
12/04/2012US8323641 Nanoparticulate compositions having lysozyme as a surface stabilizer
12/04/2012CA2708703C Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
12/04/2012CA2674543C Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
12/04/2012CA2665049C Hcv nucleoside inhibitor
12/04/2012CA2591307C Injectable veterinary composition
12/04/2012CA2575768C Method for screening toxin neutralizing peptide, stx2 inhibiting peptide and verotoxin neutralizing agent
12/04/2012CA2573479C Effective use method of medicaments and method of preventing expression of side effect
12/04/2012CA2566409C Neisseria meningitidis igtb lipo-oligo-saccharides as adjuvant
12/04/2012CA2538078C Rifalazil formulations
12/04/2012CA2524939C Avian vaccine composition for the protection of poultry against disease and infection caused by e. coli and salmonella
12/04/2012CA2485491C Injectable compositions comprising flunixin and florfenicol for treating infection in cattle and swine
12/04/2012CA2474798C Method and composition for treatment of inflammation and aids-associated neurological disorders
12/04/2012CA2463879C Glycoprotein compositions
12/04/2012CA2428834C Biodegradable poly(beta-amino esters) and uses thereof
12/04/2012CA2422294C Modulation of il-2- and il-15-mediated t cell responses
12/04/2012CA2371714C Streptococcus pneumoniae proteins and vaccines
12/04/2012CA2340304C Multicomponent vaccines
11/2012
11/29/2012WO2012162580A2 Anti-viral compounds
11/29/2012WO2012162578A2 Anti-viral compounds
11/29/2012WO2012162412A2 Synergistic combinations of polyene fungicides and non-ribosomal peptides and related methods of use
11/29/2012WO2012162407A1 Picolinamido - propanoic acid derivatives useful as glucagon receptor antagonists
11/29/2012WO2012162342A2 Influenza vaccines containing modified adenovirus vectors
11/29/2012WO2012162137A1 Hepatitis c virus particles, vaccines, compositions and methods related thereto
11/29/2012WO2012162089A2 Sgef controls macular, corpus callosum and hippocampal function and development, liver homeostasis, functions of the immune system, fever response atherosclerosis and tumorogenic cell growth
11/29/2012WO2012161755A2 Antagonism of the vip signaling pathway
11/29/2012WO2012161558A1 Mixtures of acids for use as antiviral agents
11/29/2012WO2012160218A1 Family of aryl, heteroaryl, o-aryl and o-heteroaryl carbasugars
11/29/2012WO2012160180A2 Pharmaceutical composition for administration to nails
11/29/2012WO2012160179A2 Topical pharmaceutical composition based on semifluorinated alkanes
11/29/2012WO2012160034A1 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
11/29/2012WO2012159562A1 Truncated human papillomavirus type 33 protein l1
11/29/2012WO2012159557A1 Substituted triazine phenylurea derivative and use thereof against tumors
11/29/2012WO2012159522A1 Canine influenza recombinant virus, preparation method therefor and application thereof
11/29/2012WO2012159444A1 Acupoint injection
11/29/2012WO2012137071A3 Pharmaceutical compositions for preventing and/or treating an hiv disease in humans
11/29/2012WO2012087976A3 Novel inhibitors of hepatitis c virus replication
11/29/2012US20120302816 Therapeutic compositions and methods for targeted delivery of active agents
11/29/2012US20120302644 Adhesive patch for treatment of tinea unguium
11/29/2012US20120302640 Oral formulations
11/29/2012US20120302632 Dietary control of arachidonic acid metabolism
11/29/2012US20120302629 Biomarkers for gossypol chemotherapy and methods of treating disease
11/29/2012US20120302613 Novel antibiotics
11/29/2012US20120302607 C4-substituted alpha-keto oxazoles
11/29/2012US20120302602 Vanilloid Receptor Ligand Compounds, Pharmaceutical Compositions Containing Them, a Method of Producing Them and the Use Thereof to Treat Pain and Various Other Conditions
11/29/2012US20120302599 KAT ll INHIBITORS
11/29/2012US20120302598 Imidazopyridinones
11/29/2012US20120302588 Method of enhancing hair growth
11/29/2012US20120302584 Novel salts forms of pyrimidin-5-yl acetic acid derivative
11/29/2012US20120302581 Methods and Compositions for the Treatment of RAS Associated Disorders
11/29/2012US20120302580 Optically active compound of prulifloxacin for treating infection and preparation method thereof
11/29/2012US20120302565 Kinase inhibitors for preventing or treating pathogen infection and method of use thereof
11/29/2012US20120302557 Biologically active methylene blue derivatives
11/29/2012US20120302556 Antiviral Compounds
11/29/2012US20120302542 Monobactams
11/29/2012US20120302538 Subsituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections
11/29/2012US20120302534 Derivatives of betulin
1 ... 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 ... 1798